Kristine Peterson has an estimated net worth of $2.77 Million. This is based on reported shares across multiple companies, which include ENANTA PHARMACEUTICALS INC, AMARIN CORP PLC\UK, ImmunoGen, Inc., EyePoint Pharmaceuticals, Inc., Paratek Pharmaceuticals, Inc., Immunocore Holdings plc, and ArriVent BioPharma, Inc..

2019 was Kristine Peterson's most active year for acquiring shares with 12 total transactions. Kristine Peterson's most active month to acquire stocks was the month of May. 2023 was Kristine Peterson's most active year for disposing of shares, totalling 13 transactions. Kristine Peterson's most active month to dispose stocks was the month of January. 2019 saw Kristine Peterson paying a total of $985,530.00 for 266,753 shares, this is the most they've acquired in one year. In 2019 Kristine Peterson cashed out on 333,667 shares for a total of $3,274,038.45, their largest year based on trade value.